Sofgen Pharma S.A WTS (PRCWF) Total Assets by Year
Sofgen Pharma S.A WTS closed fiscal year 2024 with $411.7M in total assets, $462.8M in total liabilities and -$51.1M in shareholder equity. Total assets fell 12.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Sofgen Pharma S.A WTS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PRCWF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing |
|---|---|---|---|---|---|---|
| Total Assets | $411.7M-12.9% | $472.5M+6.8% | $442.5M-1.7% | $450.3M+25.3% | $359.5M+6.5% | $337.7M |
| Total Liabilities | $462.8M-2.0% | $472.3M-1.3% | $478.7M-7.8% | $519.4M-15.5% | $615.0M+5.7% | $582.0M |
| Total Equity | -$51.1M-24452.9% | $210Kn/m | -$36.2Mn/m | -$69.0Mn/m | -$255.5Mn/m | -$244.3M |
PRCWF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'24Filing | Q4'23Filing | Q2'23Filing | Q4'22Filing | Q2'22Filing | Q4'21Filing | Q4'20Filing | Q4'19Filing | Q4'18Filing |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $411.7M-12.9% | $472.5M+6.8% | $490.7M | $442.5M-1.7% | N/A | $450.3M+25.3% | $359.5M+6.5% | $337.7M | N/A |
| Total Liabilities | $462.8M-2.0% | $472.3M-1.3% | $457.8M | $478.7M-7.8% | N/A | $519.4M-15.5% | $615.0M+5.7% | $582.0M | N/A |
| Total Equity | -$51.1M-24452.9% | $210Kn/m | $33.0Mn/m | -$36.2Mn/m | -$29.6M | -$69.0Mn/m | -$255.5Mn/m | -$244.3Mn/m | -$127.7M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Sofgen Pharma S.A WTS financials
Frequently Asked Questions
Sofgen Pharma S.A WTS closed fiscal year 2024 with $411.7M in total assets, $462.8M in total liabilities and -$51.1M in shareholder equity.
Sofgen Pharma S.A WTS (PRCWF) total assets fell by 12.9% year over year, from $472.5M to $411.7M in fiscal year 2024.
Across the 6 fiscal years this page covers, Sofgen Pharma S.A WTS (PRCWF) total assets went from $337.7M in fiscal year 2019 to $411.7M in fiscal year 2024.
Sofgen Pharma S.A WTS (PRCWF) reported $411.7M in total assets in Q4 2024. This represents a decrease of 12.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Sofgen Pharma S.A WTS (PRCWF) reported on that line in every period on record.